Anait S Levenson Selected Research

pterostilbene

1/2022	Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
1/2022	Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
9/2019	MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
11/2018	In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
5/2018	Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
1/2018	Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.
11/2017	Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
1/2017	Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
4/2016	Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
9/2015	Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anait S Levenson Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 08/2002
23	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2010
17	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2004
4	Breast Neoplasms (Breast Cancer) 01/2007 - 08/2002
3	Inflammation (Inflammations) 01/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 01/2018
1	Infections 01/2021
1	Obesity 01/2020
1	Adenocarcinoma 09/2019
1	Prostatic Intraepithelial Neoplasia 09/2019
1	Carcinogenesis 08/2011

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
18	ResveratrolIBA 01/2022 - 05/2003
11	pterostilbeneIBA 01/2022 - 01/2013
6	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2011
6	StilbenesIBA 01/2022 - 08/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
4	Estrogen ReceptorsIBA 01/2007 - 08/2002
3	gnetin CIBA 01/2022 - 09/2019
3	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 02/2015 - 04/2010
3	Nucleosomes (Nucleosome)IBA 02/2015 - 04/2010
3	Estrogens (Estrogen)FDA Link 01/2007 - 05/2003
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 08/2004
2	CytokinesIBA 01/2021 - 08/2013
2	PolyphenolsIBA 01/2020 - 08/2013
2	PowdersIBA 01/2020 - 11/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 09/2015
2	Cadherins (E-Cadherin)IBA 01/2018 - 03/2017
2	TensinsIBA 01/2018 - 01/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2017
2	Hormones (Hormone)IBA 11/2017 - 01/2007
2	ChromatinIBA 03/2017 - 08/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 10/2011
2	Co-Repressor ProteinsIBA 01/2013 - 04/2010
2	Estrogen Receptor alphaIBA 01/2007 - 08/2002
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2019
1	micaIBA 01/2019
1	Grape Seed ExtractIBA 11/2018
1	Histone Deacetylase 1IBA 05/2018
1	Cathepsin BIBA 01/2018
1	Cysteine Proteases (Cysteine Protease)IBA 01/2018
1	Vorinostat FDA Link 11/2017
1	Histone Deacetylase InhibitorsIBA 11/2017
1	AndrogensIBA 01/2016
1	Biological ProductsIBA 08/2015
1	Pemetrexed (MTA)FDA Link 12/2014
1	3,3',4,5'-tetrahydroxystilbeneIBA 08/2013
1	Androgen Antagonists (Antiandrogens)IBA 10/2011
1	Flutamide (Eulexin)FDA LinkGeneric 10/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	Histones (Histone)IBA 04/2010
1	Estrogen Receptor betaIBA 01/2007
1	Angiogenesis InhibitorsIBA 12/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2004
1	Furylfuramide (AF2)IBA 03/2004
1	Transforming Growth Factor alpha (TGF-alpha)IBA 05/2003
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2002
1	Complementary DNA (cDNA)IBA 08/2002
1	Tamoxifen FDA LinkGeneric 08/2002

Therapy/Procedure

4	Chemoprevention 01/2022 - 10/2011
2	Therapeutics 01/2022 - 08/2004